2018-10-02 21:15:46 | GW Pharmaceuticals 1.9M share Secondary priced at $158.00Goldman Sachs, Morgan Stanley, JPMorgan and Cowen acted as joint book running managers for the offering. | |
---|---|---|
![]() ![]()
|
| | |
| ||
| ||
| ||
|
| | |
| ||
| ||
| ||
|
| | |
| | |
| ||
| | |
| |
| | |
| ||
| ||
| | |
, |
| |
| ||
| | |
| ||
| ||
, |
| |